Converge Bio
Converge Bio integrates Generative AI with biological data.
About Converge Bio
Converge Bio integrates Generative AI with biological data. Converge Bio mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Company Facts
- Headquarters
- Wilmington
- Founded
- 2024
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $30,500,000
- Last Funding Type
- series_a
- Last Funding Date
- 2026-01-13
- Website
- https://converge-bio.com/
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical
Social Links
Canonical: https://fsome.com/organization/converge-bio-1568 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.